NEW YORK (Reuters Health) - Synthetically produced antibodies that target a component of the anthrax toxin may reduce illness and death due anthrax exposure, even after shock has set in, rat studies indicate.
NEW YORK (Reuters Health) - Synthetically produced antibodies that target a component of the anthrax toxin may reduce illness and death due anthrax exposure, even after shock has set in, rat studies indicate.
